Is a Shift in the Standard of Care Chemotherapy for Patients With Esophageal Cancer Premature?

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.1014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nimotuzumab Combined With Chemotherapy Is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer

Medical Science Monitor
Medicine
2017English

Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin—Still Not the Standard of Care for Patients With Colorectal Peritoneal Metastases

British Journal of Clinical Pharmacology
Pharmacology
2019English

The Value of GRASP on DCE-MRI for Assessing Response to Neoadjuvant Chemotherapy in Patients With Esophageal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

The Comparison of Family Member’s Satisfaction of Palliative Care and Standard Care for Patients With Incurable Cancer

Journal of Critical Care Nursing
2016English

Paradigm Shift of Esophageal Cancer Surgical Treatment

Endoskopicheskaya khirurgiya
2018English

Is Adjuvant Chemotherapy Necessary for Patients With Microinvasive Breast Cancer After Surgery?

Cancer Biology and Medicine
Cancer ResearchOncology
2016English

Barriers to Accessing Optimal Esophageal Cancer Care for Socioeconomically Disadvantaged Patients

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2017English

Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched With Patients Treated With Parenteral Chemotherapy

Anticancer Research
MedicineCancer ResearchOncology
2016English

What Is the Role of Neoadjuvant Chemotherapy, Radiation, and Adjuvant Treatment in Resectable Esophageal Cancer?

Annals of Cardiothoracic Surgery
SurgeryCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy